Nausea and Vomiting (PDQ®): Supportive care - Patient Information [NCI] - Anticipatory Nausea and Vomiting
Anticipatory nausea and vomiting may occur after several treatment sessions.
Anticipatory nausea and vomiting occur in some patients after they have had several courses of treatment. This is caused by triggers, such as odors in the therapy room. For example, a person who begins chemotherapy and smells an alcohol swab at the same time may later have nausea and vomiting at the smell of alcohol alone. The more chemotherapy sessions a patient has, the more likely it is that anticipatory nausea and vomiting will develop. The following may make anticipatory nausea and vomiting more likely:
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.
Monoclonal Gammopathy of Undetermined Significance
Treatment of monoclonal gammopathy of undetermined significance (MGUS) is usually watchful waiting. Regular blood tests to check the level of M protein in the blood and physical exams to check...
Treatment of anticipatory nausea and vomiting should begin early.
Treatment of anticipatory nausea and vomiting is more likely to work when symptoms are treated early. Although antinausea drugs do not seem to help, the following types of treatment may decrease symptoms: